CIC
CAH icon

Carnegie Investment Counsel’s Cardinal Health CAH Stock Holding History

Carnegie Investment Counsel’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Sell
1,237
-152
-11% -$31.6K 0.01% 482
2026
Q1 		$294K Buy
1,389
+152
+12% +$32.7K 0.01% 490
2025
Q4 		$254K Buy
+1,237
New +$233K ﹤0.01% 509
2025
Q3 		– Sell
-2,124
Closed -$357K – 556
2025
Q2 		$357K Buy
+2,124
New +$315K 0.01% 445

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Carnegie Investment Counsel's CAH Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Cardinal Health (CAH) stake by 11% in Q2 2026, selling an estimated $31.6K and leaving 1,237 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #482.

Carnegie Investment Counsel first reported a position in CAH in Q2 2025 and has held it in 4 quarters since. The position peaked at $357K in Q2 2025. 857 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Carnegie Investment Counsel held 1,237 shares of Cardinal Health worth $294K as of Q2 2026.
  • Carnegie Investment Counsel sold 152 Cardinal Health shares in Q2 2026, an estimated $31.6K.
  • Cardinal Health made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #482 holding.
  • Carnegie Investment Counsel first reported a position in Cardinal Health in Q2 2025 and has held it in 4 quarters since.
  • Carnegie Investment Counsel's Cardinal Health position peaked at $357K in Q2 2025.
  • 857 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.